(Q36619757)

15 August 2017

1 reference

title

Gastrointestinal stromal tumors: imatinib and beyond (English)

1 reference

15 August 2017

1 reference

Ian D Schnadig

1

1 reference

15 August 2017

Charles D Blanke

series ordinal

2

1 reference

15 August 2017

publication date

1 November 2006

1 reference

Current Treatment Options in Oncology

15 August 2017

published in

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

427-437

1 reference

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

15 August 2017

cites work

1 reference

12 December 2020

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

1 reference

12 December 2020

Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine

1 reference

12 December 2020

Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor.

1 reference

12 December 2020

Clinical management of gastrointestinal stromal tumors: before and after STI-571.

1 reference

12 December 2020

Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sa

1 reference

12 December 2020

Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up

1 reference

12 December 2020

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

12 December 2020

Diagnosis of gastrointestinal stromal tumors: A consensus approach

1 reference

12 December 2020

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

1 reference

12 December 2020

Sarcomas metastatic to the liver: response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization

1 reference

12 December 2020

Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas

1 reference

12 December 2020

Endoscopic ultrasound-guided fine-needle aspiration biopsy for the diagnosis of gastrointestinal stromal tumors in the stomach

1 reference

12 December 2020

NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines

1 reference

12 December 2020

Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas

1 reference

12 December 2020

Endoscopic ultrasound in the diagnosis, staging, and management of gastrointestinal and adjacent malignancies

1 reference

12 December 2020

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients.

1 reference

12 December 2020

Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection

1 reference

12 December 2020

Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy.

1 reference

12 December 2020

Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden

1 reference

12 December 2020

Submucosal tumors of the stomach: a study of 100 operative cases

1 reference

12 December 2020

KIT activation is a ubiquitous feature of gastrointestinal stromal tumors

1 reference

12 December 2020

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

12 December 2020

Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies

1 reference

12 December 2020

Gastrointestinal stromal tumors

1 reference

12 December 2020

Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison.

1 reference

12 December 2020

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

12 December 2020

Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging

1 reference

12 December 2020

A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S11864-006-0018-5

Identifiers

DOI

1 reference

15 August 2017

1 reference